What’s driving Australia’s PET imaging market?
The integration of AI addresses the limitations of traditional systems.
The prevalence of chronic diseases such as cancer and neurological disorders is driving Australia’s positron emission tomography (PET) imaging market to witness a compound annual growth rate (CAGR) of 3.6% through 2033.
A GlobalData report revealed that PET scan volumes in the country will grow at a CAGR of 2.2% over the same period.
Meanwhile, the integration of AI offers workflow optimisation, addressing the limitations of traditional systems.
“AI-powered innovations are a transformative step for PET imaging in Australia. By enhancing efficiency and reducing scan times,” said Jyoti Sharma, Medical Devices Analyst at GlobalData.
Sharma added that this development will result in the market being shaped by data-driven approaches and innovative technologies.